Adipocytes, visceral obesity, inflammation and cardiovascular disease;Adipocitos, obesidad visceral, inflamación y enfermedad cardiovascular

Revista Colombiana de Cardiologia

Volumn 17, Issue 5, 2010, Pages 207-213

  Manzur, Fernando ^a   Alvear, Ciro ^a   Alayón, Alicia Norma ^b  

^a UNIVERSIDAD DE CARTAGENA   (Colombia)

^b UNIVERSIDAD DE SAN BUENAVENTURA   (Colombia)

Author keywords

Adipocytes; Adipokines; Cardiovascular diseases; Inflammation; Intra abdominal fat

Indexed keywords

ADIPOCYTE; CARDIOLOGY; CARDIOVASCULAR DISEASE; HUMAN; INFLAMMATION; OBESITY; REVIEW;

EID: 78651394255     PISSN: 01205633     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0120-5633(10)70243-6     Document Type: Review

References (42)

1. Rueda-Clausen C, Silva F, López-Jaramillo P. Epidemic of obesity and overweigh in Latin America and the Caribbean. Int J Cardiol 2008; 125 (1): 111-112.
2. Rueda-Clausen CF, Lahera V, Calderón J, Bolivara IC, Castilloc VR, Gutiérrez M, et al. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. Int J Cardiol 2010; 139 (1): 32-41. Epub 2008 Oct 14.
3. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89 (6): 2583-2589.
4. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92 (3): 347-355.
5. Trayhurn P. Endrocrine and signalling role of adipose tissue: new perspectives of fat. Acta Physiol Scand 2005; 184 (4): 285-293.
6. Olimpo C, Sierra I. Avances en obesidad. Rev Fac Med Univ Nac Colomb 2004; 52 (4): 270-287.
7. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J) 2007; 83 (5 Suppl): S192-203.
8. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11 (8): 327-332.
9. Godínez S et al. La grasa visceral y su importancia en obesidad. Rev Endocrinol Nutr 2002; 10 (3): 121-127.
10. Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500 (1): 88-96. (Pubitemid 29525402)
11. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53 (5): 1285-1292.
12. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84 (1): 277-359.
13. Fruhbeck G, Gómez-Ambrosi J, Muruzabal J, Burrel MA. The adipocyte: a model for integration of endocrine and metabolic signalling in energy metabolism regulation. Am J Physiol Endocrinol Metabol 2001; 280 (6): E827-47.
14. Fonseca-Alaniz MH et al. Adipose tissue: an endocrine organ. J Pediat 2007; 83 (5 Suppl): S192-S203.
15. Caballero AE. Endotelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease. Obes Res 2003; 11 (11): 1278-1289.
16. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 2002; 25 (8): 1320-5.
17. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347 (5): 305-313.
18. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005; 288 (5): H2031-41.
19. Libby P. Changing concepts of atherogenesis. J Int Med 2000; 247 (3): 349-358.
20. Yamagishi S, Nakamura K, Jinnouchi Y, Takenaka K, Imaizumi T. Molecular mechanisms for vascular injury in metabolic syndrome. Drugs Exptl Clin Res 2005; 31 (3): 123-129. (Pubitemid 40942954)
21. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115 (5): 911-919.
22. Martínez-González J, Llorent-Cortés V, Badimón L. Biología celular y molecular de las lesiones ateroscleróticas. Rev Esp Cardiol 2001; 54 (2): 218-231. (Pubitemid 33611142)
23. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108 (15): 1772-1778. (Pubitemid 37296082)
24. Moreno PR, Fuster V. The year in atherothrombosis. JACC 2004; 44 (11): 2099-110.
25. Weisberg SP, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112 (12): 1796-1808. (Pubitemid 38063703)
26. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112 (12): 1821-1830. (Pubitemid 38063705)
27. Blüher M, Wilson-Fritch L, Leszyk J, Laustsen PG, Corvera S, Kahn. Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem 2004; 279 (30): 31902-31909. (Pubitemid 39037863)
28. Skurk C, Alberti-Huber CH. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92 (3): 1023-1033.
29. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-477.
30. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J. Clin Invest 2005; 115 (5):1111-1119.
31. Després JP. Inflammation and cardiovascular disease: is abdominal obesity the missing link? Int J Obes 2003; 27 (Suppl 3): S22-4.
32. Calabro P, Golia E, Maddaloni V, Malvezzi M, Casillo B, Calabro R, et al. Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? Intern Emerg Med 2009; 4 (1): 25-34.
33. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116 (7):1793-1801.
34. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007; 27 (1): 84-91. (Pubitemid 46370478)
35. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17 (1): 4-12.
36. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444 (7121): 860-867.
37. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96 (9): 939-949.
38. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6 (10): 772-783.
39. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11 (2): 191-198.
40. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005; 288 (5): R1220-R1225.
41. Moreno-Aliaga MJ, Campion J, Milagro F, Berjon A, Martinez JA. Adiposity and proinflammatory state: the chicken or the egg. Adipocytes 2005; 1: 1-13.
42. Piñeiro, DJ. Adipocito e inflamación. Rev Argent Cardiol 2007; 75 (1): 84-87.